Hamburg-based Topas Therapeutics, a clinical-stage biotech company, has appointed Hugo Fry as its new CEO. Fry brings three decades of experience in senior management and executive roles at both large…
Germany: Hugo Fry appointed as new CEO at Topas Therapeutics
…
…






